Immunotherapy for lung cancer
Author:
Affiliation:
1. School of Medicine and Pharmacology; University of Western Australia; Crawley Western Australia Australia
2. National Centre for Asbestos Related Diseases (NCARD); Perth Western Australia Australia
Publisher
Wiley
Subject
Pulmonary and Respiratory Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/resp.12789/fullpdf
Reference89 articles.
1. Global cancer statistics, 2012;Torre;CA Cancer J. Clin.,2015
2. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours;Goldstraw;J. Thorac. Oncol.: official publication of the International Association for the Study of Lung Cancer,2007
3. Impact of EGFR inhibitor in non-small cell lung cancer on progression-free and overall survival: a meta-analysis;Lee;J. Natl. Cancer Inst.,2013
4. First-line crizotinib versus chemotherapy in ALK-positive lung cancer;Solomon;N. Engl. J. Med.,2014
5. Ceritinib in ALK-rearranged non-small-cell lung cancer;Shaw;N. Engl. J. Med.,2014
Cited by 278 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. MDM2 inhibitors in cancer immunotherapy: Current status and perspective;Genes & Diseases;2024-11
2. Selenium nanoparticles enhance the anti-tumor immune responses of anti-4-1BB antibody and alleviate the adverse effects on mice;Immunobiology;2024-09
3. Pan-cancer analysis of immune checkpoint receptors and ligands in various cells in the tumor immune microenvironment;Aging;2024-08-07
4. The impact of the expression level of growth differentiation factor 15 in tumor tissue on the response to immunotherapy in non-small cell lung cancer;BMC Cancer;2024-08-05
5. Influence of Financial Toxicity on the Quality of Life in Lung Cancer Patients Undergoing Immunotherapy: The Mediating Effect of Self-Perceived Burden;Cancer Management and Research;2024-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3